<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
67457-847-44
</NDCCode>
<PackageDescription>
1 KIT in 1 CARTON (67457-847-44) * 20 mL in 1 VIAL, MULTI-DOSE (67457-845-50) * 20 mL in 1 VIAL (67457-846-20)
</PackageDescription>
<NDC11Code>
67457-0847-44
</NDC11Code>
<ProductNDC>
67457-847
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Ogivri
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Trastuzumab
</NonProprietaryName>
<DosageFormName>
KIT
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20191129
</StartMarketingDate>
<EndMarketingDate>
20270430
</EndMarketingDate>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA761074
</ApplicationNumber>
<LabelerName>
Mylan Institutional LLC
</LabelerName>
<SubstanceName/>
<StrengthNumber/>
<StrengthUnit/>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2023-09-07
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20191129
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20270430
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>